SCHEMBL14137147

SCHEMBL14137147

CCOC(=O)c1ccc(C)c(-c2csc3c(Nc4ccc(N5CCOCC5)cc4)ncnc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.52
GAA P10253 8/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
TDP1 Q9NUW8 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
LMNA P02545 3/20 0.52
HTT P42858 3/20 0.52
MAPK1 P28482 2/20 0.52
MC4R P32245 2/20 0.52
CLK1 P49759 1/20 0.52
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
TP53 P04637 1/20 0.49
PTK2 Q05397 1/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233153 0.87 GAA (0.50) MAPTGAASMN1; SMN2TDP1L3MBTL1
SCHEMBL14137146 0.79 BRAF (0.44) MAPTSMN1; SMN2LMNATP53PTK2
SCHEMBL2235326 0.79 PTK2 (0.51) MAPTGAASMN1; SMN2TDP1L3MBTL1
SCHEMBL14125082 0.78 PTK2 (0.50) MAPTGAASMN1; SMN2TDP1L3MBTL1
SCHEMBL2299923 0.78 PTK2 (0.50) MAPTGAASMN1; SMN2TDP1L3MBTL1
SCHEMBL14137138 0.77 KDM4E (0.38) MAPTSMN1; SMN2L3MBTL1LMNAMAPK1
SCHEMBL20895103 0.75 CSNK2A1 (0.49) MAPTGAASMN1; SMN2TDP1HTT
SCHEMBL24193422 0.75 GAA (0.59) MAPTGAASMN1; SMN2TDP1L3MBTL1
SCHEMBL14137139 0.73 STK17B (0.41) MAPTSMN1; SMN2LMNAMAPK1TP53
SCHEMBL30867020 0.72 PTK2 (0.84) PTK2BRD4SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302567-A1 BICYCLIC HETEROARYL DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302567-A1 BICYCLIC HETEROARYL DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE CDK2, SBK3, CDK2AP1 MAPT 1332/4885GAA 1653/4885SMN1; SMN2 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.